ArticleRadiation oncology (London, England)2018
In silico assessment of the dosimetric quality of a novel, automated radiation treatment planning strategy for linac-based radiosurgery of multiple brain metastases and a comparison with robotic methods.
Article in Radiation oncology (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Optimizing normal tissue objectives (NTO) in eclipse treatment planning system (TPS) for stereotactic treatment of multiple brain metastases using non-coplanar RapidArc and comparison with HyperArc techniques.Japanese journal of radiology · 2025Article
- What is the optimal isodose line for stereotactic radiotherapy for single brain metastases using HyperArc?Journal of applied clinical medical physics · 2024Article
- Dosimetric comparison of HyperArc and InCise MLC-based CyberKnife plans in treating single and multiple brain metastases.Journal of applied clinical medical physics · 2024Article
- Single isocenter dynamic conformal arcs-based radiosurgery for brain metastases: Dosimetric comparison with Cyberknife and clinical investigation.Technical innovations & patient support in radiation oncology · 2024Article
- Dose-Painting Linear Accelerator Radiosurgery of Glomus Jugulare With Dosimetric Comparison to Gamma Knife.Cureus · 2024Article
- Neurosurgical Management of Cerebrospinal Tumors in the Era of Artificial Intelligence : A Scoping Review.Journal of Korean Neurosurgical Society · 2023Article
- Dosimetric potential of knowledge-based planning model trained with HyperArc plans for brain metastases.Journal of applied clinical medical physics · 2023Article
- Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT.Radiation oncology (London, England) · 2023Article
- Clinical implementation of HyperArc.Physical and engineering sciences in medicine · 2022Article
- Single-isocenter stereotactic non-coplanar arc treatment of 200 patients with brain metastases: multileaf collimator size and setup uncertainties.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2022Article
- Radiosurgery for Five to Fifteen Brain Metastases: A Single Centre Experience and a Review of the Literature.Frontiers in oncology · 2022Article
- The new SRS/FSRT technique HyperArc for benign brain lesions: a dosimetric analysis.Scientific reports · 2021Article
- Complementing Prostate SBRT VMAT With a Two-Beam Non-Coplanar IMRT Class Solution to Enhance Rectum and Bladder Sparing With Minimum Increase in Treatment Time.Frontiers in oncology · 2021Article
- Is there a volume threshold of brain metastases for Linac-based stereotactic radiotherapy?Journal of radiosurgery and SBRT · 2021Article
- Strategies to optimize stereotactic radiosurgery plans for brain tumors with volumetric-modulated arc therapy.Journal of applied clinical medical physics · 2020Article
- Dosimetric effect of rotational setup errors in stereotactic radiosurgery with HyperArc for single and multiple brain metastases.Journal of applied clinical medical physics · 2019Article
- Dosimetric performance of two linear accelerator-based radiosurgery systems to treat single and multiplebrain metastases.The British journal of radiology · 2019Article
- Recent developments in non-coplanar radiotherapy.The British journal of radiology · 2019Review
- Multi-Institutional Dosimetric Evaluation of Modern Day Stereotactic Radiosurgery (SRS) Treatment Options for Multiple Brain Metastases.Frontiers in oncology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo appraise the dosimetric features and the quality of the treatment plan for radiosurgery of multiple brain metastases optimized with a novel automated engine and to compare with plans optimized for robotic-based delivery.
methodsA set of 15 patients with multiple brain metastases was selected for this in silico study. The technique under investigation is the recently introduced HyperArc. For all patients, three treatment plans were computed and compared: i: a HyperArc; ii: a standard VMAT; iii) a CyberKnife. Dosimetric features were computed for the clinical target volumes as well as for the healthy brain tissue and the organs at risk.
resultsThe data showed that the best dose homogeneity was achieved with the VMAT technique. HyperArc allowed to minimize the volume of brain receiving 4Gy (as well as for the mean dose and the volume receiving 12Gy, although not statistically significant). The smallest dose on 1 cm
conclusionAt treatment planning level, the study demonstrates that the use of HyperArc technique can significantly improve the sparing of the healthy brain while maintaining a full coverage of the target volumes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.